Across TCGA pan-cancer cohorts, SNORD115-11 RNA is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SNORD115-11 data layer compared with 3 for mutation status.
The strongest signal is observed in kidney chromophobe (KICH), where higher SNORD115-11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORD115-11 expression acts as an unfavorable survival marker.
KICH and BRCA are the cancer types where SNORD115-11 RNA most reproducibly stratifies survival.